Superworth

Merit Medical Systems EV/EBIT MMSI

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2012.

Today, Oct 23, 2026
28.6×
10-year median
44.2×
Against its 10-year history
7th
percentile: 0 is its lowest day, 100 its highest
10-year range
20.1× to 76.9×
Peer median
20.4×

Merit Medical Systems' EV/EBIT is 28.6× as of Oct 23, 2026.

That is below its ten-year median of 44.2×, lower than on 93% of days in the last ten years.

Over that time it ranged from 20.1× in May 2026 to 76.9× in Oct 2018.

The median for 10 medical instruments and supplies stocks of a similar size is 20.4×.

EV/EBIT over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far28.6×20.1×31.6×
202531.9×30.2×42.3×
202437.8×34.3×40.8×
202335.6×32.5×45.6×
202243.7×34.9×53.4×
202151.6×43.7×62.7×
202044.7×30.6×65.0×
201951.9×28.3×61.8×
201852.8×49.1×76.9×
201754.3×44.1×70.9×
201648.4×19.6×48.5×
201522.3×18.9×28.9×
201420.8×15.3×31.0×
201331.0×14.0×42.4×
201215.9×14.1×17.1×

Against its peers

Companies in Medical - Instruments & Supplies nearest Merit Medical Systems' size, closest first, today.

CompanyEV/EBIT
MMSIMerit Medical Systems28.6×
HAEHaemonetics26.8×
VNTVontier10.9×
MSAMSA Safety18.0×
BMIBadger Meter26.2×
ICUIICU Medical45.9×
NVSTEnvista14.9×
WRBYWarby Parkern/m
PODDInsulet20.4×
ATRCAtriCure208×
GMEDGlobus Medical16.3×
Peer median20.4×

Where Merit Medical Systems ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Merit Medical Systems

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.